Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-001069
Filing Date
2025-07-18
Accepted
2025-07-18 16:06:30
Documents
1
Period of Report
2025-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 e664709_4-whaley.html 4  
1 FORM 4 e664709_4-whaley.xml 4 14027
  Complete submission text file 0001193805-25-001069.txt   15616
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERNIX THERAPEUTICS HOLDINGS, INC. 10 NORTH PARK PLACE, SUITE 201 MORRISTOWN NJ 07960
Business Address
Whaley Glenn (Reporting) CIK: 0001724623 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 251134576